Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|July 5, 2017
Next Generation Antibody Therapeutics Using Bispecific Antibody TechnologyTomoyuki Igawa
Drug Metabolism and Pharmacokinetics|November 26, 2018
Improvement of pharmacokinetic properties of therapeutic antibodies by antibody engineeringKenta Haraya, Tatsuhiko Tachibana, Tomoyuki Igawa
Immunological Reviews|February 12, 2016
Sweeping antibody as a novel therapeutic antibody modality capable of eliminating soluble antigens from circulationTomoyuki Igawa, Kenta Haraya, Kunihiro Hattori
Methods in Molecular Biology (Clifton, N.J.)|December 13, 2018
Humanization and Simultaneous Optimization of Monoclonal AntibodyTaichi Kuramochi, Tomoyuki Igawa, Hiroyuki Tsunoda, et al.
Current Pharmaceutical Biotechnology|August 25, 2016
Fc Engineering to Improve the Function of Therapeutic AntibodiesFuta Mimoto, Taichi Kuramochi, Hitoshi Katada, et al.
Mabs|March 17, 2011
Engineering the variable region of therapeutic IgG antibodiesTomoyuki Igawa, Hiroyuki Tsunoda, Taichi Kuramochi, et al.
Drug Metabolism and Pharmacokinetics|March 6, 2016
PK/PD analysis of a novel pH-dependent antigen-binding antibody using a dynamic antibody-antigen binding modelKenta Haraya, Tatsuhiko Tachibana, Yuki Iwayanagi, et al.
Mabs|February 15, 2013
Novel asymmetrically engineered antibody Fc variant with superior FcγR binding affinity and specificity compared with afucosylated Fc variantFuta Mimoto, Tomoyuki Igawa, Taichi Kuramochi, et al.
Mabs|April 8, 2017
Identification of human IgG1 variant with enhanced FcRn binding and without increased binding to rheumatoid factor autoantibodyAtsuhiko Maeda, Yuki Iwayanagi, Kenta Haraya, et al.
Mabs|December 20, 2014
Non-antigen-contacting region of an asymmetric bispecific antibody to factors IXa/X significantly affects factor VIII-mimetic activityZenjiro Sampei, Tomoyuki Igawa, Tetsuhiro Soeda, et al.
Pageof 4